BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 7483347)

  • 1. [Programmed esophageal stimulation of the atrium and the long-term effects of anti-arrhythmia therapy of atrial fibrillation and flutter].
    Novotný E; Uhrová V; Suda J
    Vnitr Lek; 1995 Sep; 41(9):586-9. PubMed ID: 7483347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Testing the effectiveness of drug therapy in supraventricular dysrhythmias using diagnostic esophageal cardiac stimulation].
    Stípal R; Minarík T; Martínek A
    Vnitr Lek; 1991; 37(9-10):740-4. PubMed ID: 1771805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacologic maintenance of sinusal rhythm and/or control of the ventricular response in patients with atrial fibrillation or flutter].
    López Gil M; Arribas F; Hernández Afonso J; Angel Santos M; García-Cosío F
    Rev Esp Cardiol; 1996; 49 Suppl 2():32-41. PubMed ID: 8755694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatment.
    Riva S; Tondo C; Carbucicchio C; Galimberti P; Fassini G; Della Bella P
    Europace; 1999 Oct; 1(4):242-7. PubMed ID: 11220561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug and electrical therapy of supraventricular tachyarrhythmias].
    Heisel A; Jung J; Schieffer H
    Z Kardiol; 2000; 89 Suppl 3():68-74. PubMed ID: 10810788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V; Ickrath O; Seipel L
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sinus node functions, sinoatrial conduction, atrial conductivity after incipient paroxysms of atrial fibrillation and flutter in patients with ischemic heart disease].
    Olesin AI; Shabrov AV; Razumova TV; Sinenko VI; Aleksandrov VS
    Ter Arkh; 2001; 73(12):40-4. PubMed ID: 11858106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
    Andriushchenko OM; Olesin AI
    Ter Arkh; 1996; 68(5):57-60. PubMed ID: 9082603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug prevention of recurrence in paroxysmal and chronic atrial fibrillation].
    Hindricks G; Kottkamp H; Willems S; Haverkamp W; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():87-96. PubMed ID: 7846950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiarrhythmic therapy with intravenous loading dose of amiodarone: evidence for an altered response in diabetic patients.
    Iervasi G; Clerico A; Bonini R; Nannipieri M; Manfredi C; Sabatino L; Biagini A; Donato L
    Int J Clin Pharmacol Res; 1998; 18(3):109-20. PubMed ID: 9825267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The differentiated therapy of paroxysms of atrial fibrillation and flutter in patients with ischemic heart disease in relation to the duration of the arrhythmia before the start of treatment].
    Shabrov AV; Olesin AI; Golub IaV; Smolin ZIu
    Ter Arkh; 1998; 70(8):25-9. PubMed ID: 9770739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac rate normalization in chronic atrial fibrillation: comparison of long-term efficacy of treatment with amiodarone versus AV node ablation and permanent His-bundle pacing.
    Kirkutis A; Poviliŭnas A; Griciene P; Polena S; Yang S; Yalamanchi G; Gintautas J
    Proc West Pharmacol Soc; 2004; 47():69-70. PubMed ID: 15633616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].
    Vainer J; Smíd J; Cepeláková H; Hapala J; Topinka I; Topolcan O
    Vnitr Lek; 1989 Feb; 35(2):145-50. PubMed ID: 2711622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The potentials for curing atrial flutter by the combined use of transesophageal electrical stimulation and anti-arrhythmia preparations].
    Grosu AA; Shevchenko NM
    Ter Arkh; 1990; 62(1):36-9. PubMed ID: 2333614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An Italian experience of radiofrequency transcatheter ablation in type-I atrial flutter: the results and follow-up].
    Inama G; Gramegna L; Pessano P; Vergara G; Disertori M
    G Ital Cardiol; 1998 Jun; 28(6):666-77. PubMed ID: 9672780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
    Madan N; Saksena S
    Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.